ぼろぼろでてくるもののケースシリーズが多いですね…この辺のレビューで勉強します https://t.co/ATIVn28w5C
RT @DraPicon: In the absence of a potent bisphosphonate prescription at #denosumab discontinuation, the frequency of vertebral fractures is…
RT @DraPicon: In the absence of a potent bisphosphonate prescription at #denosumab discontinuation, the frequency of vertebral fractures is…
In the absence of a potent bisphosphonate prescription at #denosumab discontinuation, the frequency of vertebral fractures is common or frequent. Prescribing bisphosphonate before & after stopping denosumab may reduce the risk https://t.co/00yyiiPNYs
@estebanjodar @mangascruz @antares89 @martinfd78 @joaqmorera @JAGarciaPastor @gglg12 @LourdesGDoncel @UCAMIraras Sin duda, hay que verlo con cautela pero hay varios artículos en relación al tema👉🏾incertidumbre en la interrupción de denosumab. Es tratamient
RT @Osteoporosis_NL: Stopping Denosumab. Lamy O et al. Curr Osteoporos Rep. 2019 Jan 18 review https://t.co/pNxRqg3gSa … ≥ 1/100 and < 1/1…
Stopping Denosumab. Lamy O et al. Curr Osteoporos Rep. 2019 Jan 18 review https://t.co/pNxRqg3gSa … ≥ 1/100 and < 1/10 in five recent case series multiple vertebral fractures; median number of VF was 5 within 7 to 20 months (median 11) after the last